Endocytic pathways mediating oligomeric Abeta42 neurotoxicity.
about
Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal CompoundsTargeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeuticsTDP-43: a new player on the AD field?The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's diseaseDynamin 1 regulates amyloid generation through modulation of BACE-1APP processing in Alzheimer's diseaseMechanisms of U87 astrocytoma cell uptake and trafficking of monomeric versus protofibril Alzheimer's disease amyloid-β proteinsDistinct internalization pathways of human amylin monomers and its cytotoxic oligomers in pancreatic cellsNovel analogues of chlormethiazole are neuroprotective in four cellular models of neurodegeneration by a mechanism with variable dependence on GABA(A) receptor potentiation.How the Wnt signaling pathway protects from neurodegeneration: the mitochondrial scenarioRoles of rho GTPases in intracellular transport and cellular transformation.Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis.The potential role of rho GTPases in Alzheimer's disease pathogenesis.Mechanisms of amyloid-Beta Peptide uptake by neurons: the role of lipid rafts and lipid raft-associated proteins.Formation and propagation of tau oligomeric seeds.Amyloidogenicity and toxicity of the reverse and scrambled variants of amyloid-β 1-42Aβ internalization by neurons and glia.Amyloid-β42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations.Derailed intraneuronal signalling drives pathogenesis in sporadic and familial Alzheimer's disease.The Molecular Physiopathogenesis of Islet Amyloidosis.Melatonin ameliorates anxiety and depression-like behaviors and modulates proteomic changes in triple transgenic mice of Alzheimer's disease.
P2860
Q26749061-EE9CD422-17A1-4406-9316-A55AFFE5B750Q26822002-E720717A-6808-4C33-9B3F-263C559467E4Q26823723-263B0B9E-BE98-4E9B-B151-74DA19254EA4Q26827353-6C82FF65-34E5-4F67-8318-2593C393F5FFQ27318742-3FF0BA21-EA66-436C-A75B-0A1F46738954Q27694738-95B6FE9E-57F4-41BE-8C20-ECFA1299F32FQ30436205-F01F1192-C902-4C6B-9F56-76BE5F5D08A5Q34982786-A090376E-A5FD-4600-930C-51B93EDD7350Q35015325-EF05676B-8FDB-45E5-BB95-6906AA708F0AQ35569964-C18CC41C-17D2-44FC-8F7D-4A021EE69BD3Q36820419-16091753-3146-45FE-98AD-E63A24D64AABQ38099153-2CB28A0F-245A-440A-8109-6946925A4A83Q38180966-7811B789-488B-466E-B85C-5DD50FCD7237Q41487372-6FE24BD7-2B15-4EAF-BF24-2891B002EBABQ41820128-C3CE98A6-7912-4517-B4F6-EB48A2D061D6Q42314615-2ACF2706-7D6A-4854-B758-BE367170C0EEQ42620803-86C57A3D-0E99-47D6-9D6D-2142F64C8903Q42651770-A1BDA074-395D-4EE6-9270-7DE13C58C174Q42872730-D50A1809-32C0-4C1B-AF6A-05DFC24F2815Q46282033-BA9CB5FF-A760-492E-BE96-1CABB8CCCD74Q47858487-E2A476EB-CDA6-4900-9AD7-C60CAF3BA9B8
P2860
Endocytic pathways mediating oligomeric Abeta42 neurotoxicity.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Endocytic pathways mediating oligomeric Abeta42 neurotoxicity.
@en
type
label
Endocytic pathways mediating oligomeric Abeta42 neurotoxicity.
@en
prefLabel
Endocytic pathways mediating oligomeric Abeta42 neurotoxicity.
@en
P2093
P2860
P356
P1476
Endocytic pathways mediating oligomeric Abeta42 neurotoxicity
@en
P2093
Chunjiang Yu
Evelyn Nwabuisi-Heath
Kevin Laxton
P2860
P2888
P356
10.1186/1750-1326-5-19
P50
P577
2010-05-17T00:00:00Z
P5875
P6179
1033302431